Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-496-7 | CAS number: 350-03-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In vitro: - Gene mutation (Bacterial reverse mutation assay / Ames test), Salmonella typhimurium LT 2 (TA 97a, TA 98, TA 100, TA 102, TA 1535): negative with and without metabolic activation [OECD 471, EU Method B.13/14, GLP]
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP - Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: SOP 118 008 03 edition 11, valid from 01. Oct. 2014 "Bestimmung des erbgutverändernden Potentials mit dem Bacterial-Reverse-Mutation-Test (Ames-Test)"
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- The strains used are mutants derived from Salmonella typhimurium LT2, mutations of the strains are listed below:
hisD6610 (category: frame shift, effect: histidine deficiency) present in strain TA97a
hisD3052 (category: frame shift, effect: histidine deficiency) present in strain TA98
hisG46 (category: base pair substitution, effect: histidine deficiency) present in strains TA100 and TA1535
hisG428 (category: base pair substitution, effect: histidine deficiency) present in strain TA102
uvrB (category: deletion, effect: UV sensitivity, biotine deficiency) present in strains TA97a, TA98, TA100 and TA1535
rfa (category: deletion, effect: lipopolysaccharide side chain deficiency) present in strains TA97a, TA98, TA100, TA 102 and TA1535
pKM101 (category: plasmide, effect: ampicillin resistance) present in strains TA97a, TA98, TA100 and TA 102
pAQ1 (category: plasmide, effect: tetracyclin resistance) present in strain TA 102 - Species / strain / cell type:
- S. typhimurium, other: TA97a, TA98, TA100, TA102 and TA1535
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9-mix induced by Aroclor 1254
- Test concentrations with justification for top dose:
- First experiment: 50, 150, 500, 1500 and 5000 µg/plate with and without metabolic activation
Second experiment: 313, 625, 1250, 2500 and 5000 µg/plate with and without metabolic activation - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle:
In a non-GLP pre-test the solubility of the test item was determined: The test item is sufficiently soluble in DMSO (no precipitates were visible). A solution containing 50 ± 5 g/L will be prepared for the tests. In a non-GLP pre-test, possible turbidity of the resulting test item solutions in combination with phosphate buffer was tested, too. The highest test item concentration (5 mg/plate) was not turbid.
On the base of these results the preparation of the test item was the same for both experiments. On the day of the start of the respective experiment, a stock solution containing 50 g/L of the test item in DMSO was prepared. DMSO was chosen as vehicle, because the test item was sufficiently soluble, and this solvent does not have any effects on the viability of the bacteria or the number of spontaneous revertants. The stock solution was used to prepare the geometric series of the concentrations to be tested. Each solution was membrane filtrated to accomplish sterility. - Untreated negative controls:
- other: solvent control (DMSO)
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 4-nitro-1,2-phenylenediamine (TA97a, TA98 & TA102); sodium azide (TA100 & TA1535); 2-amino-anthracene (TA97a, TA100, TA102 & TA1535); benzo-a-pyrene (TA98)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Preincubation period: Only in the 2nd experiment the materials were gently vortexed in a test tube and incubated at 37 °C for 20 minutes (in the 1st experiment they were directly poured onto the selective agar plates).
- Exposure duration: 48 h
SELECTION AGENT (mutation assays): histidine
NUMBER OF REPLICATIONS: Per strain and dose, four plates with and four plates without S9 mix were used; 2 experiments were performed.
DETERMINATION OF CYTOTOXICITY
- Method: Assessment for numbers of revertant colonies and examination for effects on the growth of the bacterial background lawn.
OTHER:
- Origin and Culture
Salmonella typhimurium (all strains used) were obtained from TRINOVA BioChem and were stored as lyophilisates in the fridge at 2-8 °C. The lyophilisates were used to prepare permanent cultures which were filled into vials and stored at < -75°C. One day before the start of each experiment, one vial per strain to be used was taken from the deep freezer. The surface was scraped with an inoculation loop and the aliquot was put into a culture vessel containing nutrient broth. After incubation over night at 37°C, the cultures were used in the experiment. During the test, the cultures were stored at room temperature as to prevent changes in the titre. - Evaluation criteria:
- The colonies were counted visually, the numbers were recorded. A spreadsheet software (Microsoft Excel®) was used to calculate mean values and standard deviations of each treatment, solvent control and positive control. The increase factor f(I) of revertant induction (mean revertants divided by mean spontaneous revertants) and the absolute number of revertants (“Rev. abs.”, mean revertants less mean spontaneous revertants) were also calculated.
A test item is considered to have mutagenic potential, if a significant, reproducible increase of revertant colonies per plate (increase factor ≥ 2) in at least one strain can be observed. A concentration-related increase over the range tested can also be taken as a sign of mutagenic activity. - Species / strain:
- S. typhimurium, other: TA97a, TA98, TA100, TA102 and TA1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- with and without metabolic activation
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- other: see vehicle control
- Positive controls validity:
- valid
- Additional information on results:
- The test item did not show mutagenic effects in both experiments. The number of revertant colonies was not increased in comparison with the spontaneous revertants (solvent only). Cytotoxicity of the test item was not detected. The bacterial background lawn was visible and the number of revertants was not significantly decreased. Therefore it can be stated, that under the test conditions, the test item 3-Acetylpyridine is not mutagenic in the Bacterial Reverse Mutation Test using Salmonella typhimurium, strains TA97a, TA98, TA100, TA102 and TA1535.
The confirmation tests of the genotype didn't show any irregularities. The control of the titre was above the demanded value. The numbers of revertant colonies of the positive controls were within the range of the historical data of the laboratory (see Attachment 1) and were definitely increased in comparison with the negative controls, as well as showing mutagenic potential of the diagnostic mutagenes.
Spontaneous revertants were not all within the normal range in comparison with the historical data of the laboratory. The values, which lay outside of the historical data do not affect the validity of the study and the deviations are marginal. For these reasons, the result of the test is considered valid. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results:
negative with metabolic activation
negative without metabolic activation
The study was performed according to the OECD TG471 and EU Method B.13/14 (GLP) without deviations and therefore considered to be of the highest quality (reliability Klimisch 1). The validity criteria of the test system are fulfilled. In both experiments no significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, either with or without metabolic activation. The test material was therefore considered to be non-mutagenic under the conditions of this test. - Executive summary:
Two valid experiments were performed according to the OECD 471 resp. EU Method B.13/14 (GLP):
First Experiment
Five concentrations of the test item, dissolved in DMSO (ranging from 50 to 5000 µg/plate) were used. Five strains of Salmonella typhimurium (TA97a, TA98, TA100, TA102 (genetically manipulated) and TA1535) were exposed to the test item both in the presence and in the absence of a metabolic activation system (S9-mix, rat liver S9-mix induced by Aroclor 1254) for 48 hours, using the plate incorporation method. None of the concentrations caused a significant increase in the number of revertant colonies in the tested strains. The test item did not show any mutagenic effects in the first experiment. The test item showed no precipitates on the plates in all tested concentrations. No signs of toxicity towards the bacteria could be observed. The sterility control and the determination of the titre did not show any inconsistencies. The determined values for the spontaneous revertants of the negative controls were in the normal range. All positive controls showed mutagenic effects with and without metabolic activation.
Second Experiment
To verify the results of the first experiment, a second experiment was performed, using five concentrations of the test item (ranging from 313 to 5000 µg/plate) and a modification in study performance (pre-incubation method). The test item did not show mutagenic effects in the second experiment, either. The test item showed no precipitates on the plates in all tested concentrations. No signs of toxicity towards the bacteria could be observed. The sterility control and the determination of the titre did not show any inconsistencies. The determined values for the spontaneous revertants of the negative controls were in the normal range. All positive controls showed mutagenic effects with and without metabolic activation.
Under the conditions of the test, the test item didn't show mutagenic effects towards Salmonella typhimurium, strains TA97a, TA98, TA100, TA102 and TA1535. Therefore, no concentration-effect relationship could be determined and the test item 3 -Acetylpyridine is considered as "not mutagenic under the conditions of the test".
Reference
First Experiment
- Confirmation of the Criteria and Validity: The treatments for the sterility control and the determination of the titre didn't show any inconsistencies. The determined values for the spontaneous revertants of the negative controls were in the normal range of the test laboratory (historical data of the laboratory see Attachment 1). All positive controls (diagnostic mutagenes) showed mutagenic effects with and without metabolic activation.
- Solubility and Toxicity: The test item was dissolved in DMSO. A stock solution containing 50 g/L was prepared. In this experiment, the test item showed no precipitates on the plates in all tested concentrations. No signs of toxicity towards the tested strains could be observed. The background lawn was visible and the number of revertant colonies was not reduced.
- Mutagenicity: No significant increase of the number of revertant colonies in the treatments with and without metabolic activation could be observed. No concentration-related increase over the tested range was found. Therefore, the test item is stated as not mutagenic under the test conditions.
The mean revertant values of the four replicates are presented in the following table.
Strain | TA97a | TA98 | TA100 | TA102 | TA1535 | ||||||
Induction | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | |
H2O | Mean | 125 | 112 | 16 | 15 | 103 | 105 | 345 | 347 | 13 | 14 |
sd | 6.0 | 6.0 | 1.5 | 1.5 | 3.5 | 12.5 | 14.0 | 56.0 | 1.0 | 1.5 | |
DMSO | Mean | 117 | 114 | 14 | 14 | 103 | 105 | 316 | 340 | 12 | 14 |
sd | 1.5 | 1.5 | 1.5 | 4.0 | 6.1 | 12.8 | 42.3 | 73.0 | 1.5 | 0.6 | |
Positive Controls* | Mean | 465 | 393 | 484 | 102 | 531 | 508 | 959 | 1212 | 108 | 108 |
sd | 24.4 | 34.9 | 34.9 | 10.1 | 79.4 | 50.0 | 135.4 | 92.3 | 1.5 | 6.5 | |
f(I) | 3.97 | 3.45 | 34.57 | 7.29 | 5.16 | 4.84 | 3.03 | 3.56 | 8.31 | 7.71 | |
5000 µg/pl. | Mean | 125 | 137 | 11 | 12 | 103 | 102 | 347 | 349 | 14 | 12 |
sd | 11.5 | 6.7 | 1.5 | 3.2 | 6.1 | 9.3 | 18.0 | 12.9 | 4.0 | 1.5 | |
f(I) | 1.00 | 1.22 | 0.69 | 0.80 | 1.00 | 0.97 | 1.01 | 1.01 | 1.08 | 0.86 | |
1500 µg/pl. | Mean | 120 | 137 | 13 | 15 | 92 | 101 | 327 | 339 | 12 | 14 |
sd | 4.9 | 5.6 | 2.1 | 2.6 | 7.1 | 15.1 | 2.3 | 60.1 | 1.0 | 3.8 | |
f(I) | 0.96 | 1.22 | 0.81 | 1.00 | 0.89 | 0.96 | 0.95 | 0.98 | 0.92 | 1.00 | |
500 µg/pl. | Mean | 122 | 124 | 17 | 12 | 93 | 95 | 293 | 317 | 11 | 9 |
sd | 1.5 | 3.2 | 0.6 | 2.3 | 2.0 | 1.5 | 71.8 | 26.6 | 2.5 | 1.2 | |
f(I) | 0.98 | 1.11 | 1.06 | 0.80 | 0.90 | 0.90 | 0.85 | 0.91 | 0.85 | 0.64 | |
150 µg/pl. | Mean | 125 | 131 | 15 | 14 | 94 | 107 | 337 | 344 | 14 | 12 |
sd | 18.6 | 10.6 | 2.1 | 1.5 | 2.1 | 9.5 | 14.0 | 25.0 | 1.2 | 2.9 | |
f(I) | 1.00 | 1.17 | 0.94 | 0.93 | 0.91 | 1.02 | 0.98 | 0.99 | 1.08 | 0.86 | |
50 µg/pl. | Mean | 132 | 155 | 18 | 14 | 94 | 97 | 323 | 333 | 11 | 12 |
sd | 8.5 | 9.7 | 0.6 | 3.2 | 1.2 | 1.5 | 40.9 | 10.1 | 1.0 | 2.0 | |
f(I) | 1.06 | 1.38 | 1.13 | 0.93 | 0.91 | 0.92 | 0.94 | 0.96 | 0.85 | 0.86 |
f(I) = increase factor
* Different positive controls were used
To verify this result, a second experiment was performed using the pre-incubation method.
Second Experiment
- Confirmation of the Criteria and Validity: The treatments for the sterility control and the determination of the titre didn't show any inconsistencies. The determined values for the spontaneous revertants of the negative controls were in the normal range of the test laboratory (historical data of the laboratory see Attachment 1). All positive controls (diagnostic mutagenes) showed mutagenic effects with and without metabolic activation.
- Solubility and Toxicity: The test item was dissolved in DMSO. A stock solution containing 50 g/L was prepared. In this experiment, the test item showed no precipitates on the plates in all tested concentrations. No signs of toxicity towards the tested strains could be observed. The background lawn was visible and the number of revertant colonies was not significantly reduced.
- Mutagenicity: No significant increase of the number of revertant colonies in the treatments with and without metabolic activation was observed. No concentration-related increase over the tested range was found. Therefore, the test item is stated as not mutagenic under the test conditions.
The mean revertant values of the four replicates are presented in the following table.
Strain | TA97a | TA98 | TA100 | TA102 | TA1535 | ||||||
Induction | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | |
H2O | Mean | 129 | 124 | 14 | 13 | 135 | 133 | 365 | 370 | 14 | 10 |
sd | 8.5 | 16.9 | 1.5 | 0.0 | 6.1 | 13.1 | 17.0 | 23.6 | 4.0 | 0.6 | |
DMSO | Mean | 109 | 109 | 12 | 10 | 132 | 139 | 325 | 397 | 14 | 14 |
sd | 7.8 | 6.5 | 2.6 | 0.0 | 5.9 | 8.1 | 54.3 | 19.7 | 3.1 | 3.2 | |
Positive Controls* | Mean | 499 | 456 | 109 | 99 | 555 | 717 | 1076 | 1071 | 165 | 134 |
sd | 44.1 | 73.0 | 1.2 | 10.1 | 36.1 | 184.0 | 133.1 | 63.5 | 39.3 | 6.7 | |
f(I) | 4.58 | 4.18 | 9.08 | 9.90 | 4.11 | 5.16 | 3.31 | 2.70 | 11.79 | 9.57 | |
5000 µg/pl. | Mean | 111 | 117 | 10 | 12 | 104 | 101 | 196 | 202 | 9 | 12 |
sd | 2.3 | 4.5 | 1.7 | 2.5 | 5.5 | 10.7 | 14.0 | 44.1 | 1.0 | 4.0 | |
f(I) | 1.02 | 1.07 | 0.83 | 1.20 | 0.79 | 0.73 | 0.60 | 0.51 | 0.64 | 0.86 | |
2500 µg/pl. | Mean | 123 | 116 | 9 | 12 | 107 | 118 | 135 | 211 | 9 | 10 |
sd | 13.6 | 7.0 | 3.2 | 4.4 | 7.5 | 23.6 | 1.2 | 76.4 | 3.2 | 2.5 | |
f(I) | 1.13 | 1.06 | 0.75 | 1.20 | 0.81 | 0.85 | 0.42 | 0.53 | 0.64 | 0.71 | |
1250 µg/pl. | Mean | 110 | 120 | 15 | 13 | 102 | 101 | 206 | 261 | 15 | 12 |
sd | 6.4 | 2.0 | 2.3 | 2.6 | 8.7 | 8.1 | 50.0 | 33.8 | 4.5 | 3.2 | |
f(I) | 1.01 | 1.10 | 1.25 | 1.30 | 0.77 | 0.73 | 0.63 | 0.66 | 1.07 | 0.86 | |
625 µg/pl. | Mean | 119 | 126 | 11 | 10 | 112 | 122 | 267 | 253 | 10 | 11 |
sd | 6.4 | 2.1 | 3.5 | 1.5 | 10.4 | 24.2 | 27.7 | 41.6 | 0.6 | 2.0 | |
f(I) | 1.09 | 1.16 | 0.92 | 1.00 | 0.85 | 0.88 | 0.82 | 0.64 | 0.71 | 0.79 | |
313 µg/pl. | Mean | 117 | 122 | 7 | 11 | 105 | 75 | 265 | 246 | 8 | 11 |
sd | 4.2 | 2.0 | 1.5 | 0.6 | 4.6 | 6.2 | 14.0 | 52.9 | 1.5 | 1.5 | |
f(I) | 1.07 | 1.12 | 0.58 | 1.10 | 0.80 | 0.54 | 0.82 | 0.62 | 0.57 | 0.79 |
f(I) = increase factor
* Different positive controls were used
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
There is one guideline study (OECD 471 and EU Method B.13/14) available on in vitro genetic toxicity available, assessed with Klimisch 1 and hence considered as sufficiently reliable to cover this endpoint:
The test item did not show mutagenic effects in both experiments. The number of revertant colonies was not increased in comparison with the spontaneous revertants (solvent only). Cytotoxicity of the test item was not detected. The bacterial background lawn was visible and the number of revertants was not significantly decreased. Therefore it can be stated, that under the test conditions, the test item 3-Acetylpyridine is not mutagenic in the Bacterial Reverse Mutation Test using Salmonella typhimurium, strains TA97a, TA98, TA100, TA102 and TA1535.
The confirmation tests of the genotype didn't show any irregularities. The control of the titre was above the demanded value. The numbers of revertant colonies of the positive controls were within the range of the historical data of the laboratory and were definitely increased in comparison with the negative controls, as well as showing mutagenic potential of the diagnostic mutagenes.
Spontaneous revertants were not all within the normal range in comparison with the historical data of the laboratory. The values, which lay outside of the historical data do not affect the validity of the study and the deviations are marginal. For these reasons, the result of the test is considered valid.
With regard to the data requirements as set out in Annex VII of REACH, the available GLP guideline study, which provides consistent results, is sufficient, no data gaps were identified and there are also no indications that the negative results are not suitable for human risk assessment. Hence, no further studies need to be conducted.
Justification for classification or non-classification
The test material does not meet the criteria for classification and will not require labelling as a mutagen in accordance with European Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.